Overview

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Treatments:
Nebivolol